BDBM326290 (R)-4-((1- cyclobutylethyl)amino)- 7-methyl-6-(m-tolyl)-5- (4- (trifluoromethyl)benzyl)- 5H-pyrrolo[3,2- d]pyrimidine-2- carboxylic acid::US9637493, 1.4

SMILES C[C@@H](Nc1nc(nc2c(C)c(-c3cccc(C)c3)n(Cc3ccc(cc3)C(F)(F)F)c12)C(O)=O)C1CCC1

InChI Key InChIKey=NJVOPBLDDWXZHO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 326290   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM326290((R)-4-((1- cyclobutylethyl)amino)- 7-methyl-6-(m-t...)
Affinity DataIC50: 130nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2019
Entry Details
US Patent